Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers

Taking stock of the drug industry, from the lab to the medicine chest

September 17, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Kevin Dietsch/Getty Images STAT+ | Express Scripts sues FTC over a 'biased' report about pharmacy benefit managers The company wants the agency's "unlawful report" to be vacated and says it should "take steps" to correct the "false statements" made about PBMs. By Ed Silverman STAT+ | U.S. agency threatens J&J with sanctions if it switches payments to 340B hospitals Last month, J&J said it would change payment terms for its Xarelto blood thinner and the Stelara psoriasis treatment through the 340B program. By Ed Silverman STAT+ | What pharma companies and insurers think about Medicare's plan to cover digital treatments Developers of digital treatments have been lobbying for Medicare coverage for years as it could prompt reimbursement by commercial insurers. By Mario Aguilar Adobe STAT+ | Most cardiovascular devices with serious safety recalls aren't tested in patients The new data comes as a government watchdog is looking into how the FDA authorizes medical devices and handles safety recalls. By Katie Palmer

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser